Soligenix Inc. (SNGX)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $7.50M
Last updated: Nov 17, 2026 at 4:23 PM ET
Soligenix Inc. (SNGX) Statistics
Soligenix (SNGX) has a market cap of $7.50M. Its share count is up 411.53% from a year earlier. It holds $9.02M more cash than debt, 120.29% of its market cap.
Total Valuation
| Market Cap | $7.50M |
|---|---|
| Latest price (Nov 17, 2026) | $0.28 |
Key Dates
The next earnings report is expected on Mar 29, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Mar 29, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 6, 2026 |
| Fiscal Year End | December |
Price Statistics
The stock is down 79.53% over 52 weeks and trades 20.00% below its 50-day average.
| Beta (1Y) | 2.26 |
|---|---|
| 52-Week Change | -79.53% |
| 1-Month Change | -18.39% |
| 3-Month Change | -26.40% |
| 6-Month Change | -25.32% |
| 5-Year Change | -99.85% |
| 10-Year Change | -99.97% |
| Total Return (1Y) | -79.53% |
| Total Return (3Y CAGR) | -64.72% |
| Total Return (5Y CAGR) | -73.28% |
| Max Drawdown (1Y) | -83.02% |
| Max Drawdown (3Y) | -98.21% |
| Sharpe Ratio (1Y) | -1.01 |
| Correlation with SPY (1Y) | 0.20 |
| 50-Day Average | $0.35 |
| 200-Day Average | $0.62 |
| 52-Week Range | $0.27 to $1.70 |
| RSI (14 Days) | 26.0 |
| Average Volume (20 Days) | 151.17K |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 3.00x current liabilities, and total debt is 0.00x shareholder equity.
| Current Ratio | 3.00x |
|---|---|
| Quick Ratio | 3.00x |
| Debt / Equity | 0.00x |
Returns and Efficiency
Return on equity is -136.54% and return on assets is -90.23% over the last 12 months.
| Return on Equity (ROE) | -136.54% |
|---|---|
| Return on Assets (ROA) | -90.23% |
| ROA (5Y Average) | -83.64% |
Scores
SNGX has a Piotroski F-Score of 2 of 9, in the weak band of 0 to 2.
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Piotroski F-Score | 2 of 9 |
|---|---|
| Piotroski Strength | Weak |
Income Statement
Revenue of $0 over the last 12 months is down 100.00% from the 12 months before.
| Revenue | $0 |
|---|---|
| Revenue Growth (YoY) | -100.00% |
| Gross Profit | -$1.00K |
| Operating Income | -$9.55M |
| Pretax Income | -$9.05M |
| Net Income | -$8.54M |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 66.17% of the $9.46M in total assets.
| Cash and Equivalents | $9.02M |
|---|---|
| Total Debt | $0 |
| Net Cash | $9.02M |
| Net Cash Per Share | $0.41 |
| Working Capital | $6.11M |
| Shareholder Equity | $6.26M |
| Book Value Per Share | $0.28 |
| Total Assets | $9.46M |
| Total Liabilities | $3.21M |
Balance sheet as of Sep 30, 2026.
Cash Flow
| Operating Cash Flow | -$8.23M |
|---|---|
| FCF Per Share | -$0.38 |
| Depreciation and Amortization | $4.29K |
| Share Repurchases | $252.07K |
Trailing 12 months through Sep 30, 2026.
Dividends and Yields
SNGX does not pay a dividend.
| Buyback Yield | -103.50% |
|---|---|
| Shareholder Yield | -103.50% |
Stock Splits
The last split was a 1-for-16 reverse split on Jun 6, 2024.
| Last Split Date | Jun 6, 2024 |
|---|---|
| Split Type | Reverse split |
| Split Ratio | 1:16 |
Price Target
Analyst price targets are part of paid GNG plans. See plans
Frequently Asked Questions About SNGX
What is SNGX's market cap?
Soligenix has a market cap of $7.50M.
How many shares of SNGX are outstanding?
Soligenix has 22.15M shares outstanding. The count is up 411.53% from a year earlier.
Does SNGX pay a dividend?
No. Soligenix does not pay a dividend.
How much debt does SNGX have?
Soligenix has $0 of total debt and $9.02M of cash and equivalents, a net cash position of $9.02M.
SNGX pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors